1
De Groot, S, Sleijfer, S, Redekop, W.K, Oosterwijk, E, Haanen, J.B.A.G, Kiemeney, L.A.L.M, Uyl-de Groot, C.A
2016
2016
Volltext
Weitere Treffer
Suche einschränken
Suchfilter entfernen
Filter aufheben
Schlagwörter: everolimus
Filter aufheben
Schlagwörter: human
Filter aufheben
Schlagwörter: overall survival
Filter aufheben
Schlagwörter: pazopanib
Filter aufheben
Schlagwörter: sunitinib
Filter aufheben
Schlagwörter: survival time
Filter aufheben
Personen: Sleijfer, S
Article
8
Carcinoma
8
Netherlands
8
Renal Cell
8
adult
8
age
8
aged
8
alpha interferon
8
antineoplastic agent
8
bevacizumab
8
bone metastasis
8
brain metastasis
8
cancer prognosis
8
cancer registry
8
cancer survival
8
clinical effectiveness
8
clinical practice
8
cohort analysis
8
controlled study
8
drug use
8
drug utilization
8
everolimus
female
8
high risk population
8
human
indole derivative
8
kidney carcinoma
8
liver metastasis
8
lung metastasis
8
major clinical study
8
male
8
metastasis
8
metastasis resection
8
molecularly targeted therapy
8
nephrectomy
8
number of metastatic site
8
oncological parameters
8
overall survival
pazopanib
pyrimidine derivative
8
pyrrole derivative
8
sorafenib
8
sulfonamide
8
sunitinib
survival time
systemic therapy
8
temsirolimus
8
trend study
8